FedEx expands Korean life sciences center to boost APAC healthcare logistics

The Asia-Pacific pharmaceutical market is projected to reach $290 billion by 2028. The region conducts about 50% of global clinical trials, highlighting its importance in drug development worldwide. Healthcare clients require precise temperature control services for product efficacy. FedEx leverages decades of experience through a global transportation network, customized special service delivery options (SpS), and a network of life sciences centers worldwide. These centers are located in South Korea, Singapore, Tokyo, Mumbai, Memphis, and Veldhoven. Additionally, FedEx operates over 130 cold chain facilities globally to ensure consistent temperature control across logistics networks.

Kawal Preet, President of FedEx Asia Pacific Division stated: “Driven by demographic shifts, infrastructure investments, and rapid technological advancements, the healthcare industry in Asia Pacific is evolving at an unprecedented pace. With decades of healthcare transportation expertise combined with our extensive global network and differentiated solutions offering we are actively enabling this growth."

FedEx Clinical Care focuses on providing end-to-end transportation services for time- and temperature-sensitive healthcare shipments using controlled packaging solutions along with priority handling clearance supported by sensor-based real-time tracking intervention technology ensuring deliveries within 24-48 hours safely reaching their destinations.

In August this year FedEx introduced FedEx Surround—a monitoring intervention intelligent solution designed specifically enhancing controllability visibility over important shipments including those related medical purposes.

For more information on FedEx's healthcare solutions visit: https://fedexbusinessinsights.com/healthcare/.